The long-term survival chances of patients with breast cancer plummet if the cancer recurs or spreads to other parts of the body in the process known as metastasis.
So the National Breast Cancer Foundation recently funded a five-year, $5 million National Collaborative Research Program to investigate metastasis and discover potential drugs to stop or slow it. The EMPathy Breast Cancer Network program was also charged with finding ways of diagnosing metastasis before it occurs. The research is highly dependent on the latest sequencing technology and demands the massive computer power and sophisticated data handling techniques of modern bioinformatics.
Continue reading Supercomputer probes cancer crisis point